Tobi Podhaler
My Prescription
Payment
Select pharmacy
$436.95
Print or send this coupon to your phone
AlbertsonsPowered byAbout Tobi Podhaler
Drug Details
Tobramycin is prescribed for individuals with cystic fibrosis to address persistent lung infections caused by the bacteria Pseudomonas aeruginosa. Cystic fibrosis leads to the production of thick, sticky mucus that can obstruct the lungs' airways, causing severe breathing difficulties and lung infections. Tobramycin is classified as an aminoglycoside antibiotic and functions by inhibiting bacterial growth, specifically targeting Pseudomonas aeruginosa. This action reduces lung infections and damage, subsequently enhancing breathing for those affected.
Price history for Tobi Podhaler
8 Capsules, 28MG
Average retail price for Tobi Podhaler
Average SaveHealth price for Tobi Podhaler
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Tobi Podhaler dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 28MG | 8 Capsules | $439.92 | $54.99 |
| 28MG | 56 Capsules | $3,031.47 | $54.13 |
| 28MG | 224 Capsules | $12,101.87 | $54.03 |
Tobi Podhaler FAQs
TOBI Podhaler is used for the management of chronic lung infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis. It is an inhaled antibiotic that helps reduce the frequency of these infections and improve lung function.
Yes, there is a generic version of TOBI Podhaler. The generic name is tobramycin inhalation powder.
Yes, the TOBI Podhaler is FDA approved. It is used for the management of cystic fibrosis patients with Pseudomonas aeruginosa infections.
Tobi is an inhaled antibiotic used primarily to treat lung infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis.
Inhaled tobramycin is used to treat lung infections caused by Pseudomonas aeruginosa in patients with cystic fibrosis.